Gilead Sciences (GILD)

Cost of Revenue

$1.58B

Quarterly · Period ending: · USD

GILD logo

GILD Cost of Revenue

Latest reported$1.58B
GILD Quarterly Cost of Revenue ($0.00 → $1.58B)
High-resolution chart · PNG

GILD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,579,000,000
1,445,000,000
1,624,000,000
1,569,000,000
1,501,000,000
1,540,000,000
1,581,000,000
1,574,000,000
1,544,000,000
1,552,000,000
2,090,000,000
1,565,000,000
1,442,000,000
1,401,000,000
1,396,000,000
1,395,000,000
1,442,000,000
1,424,000,000
2,627,000,000
1,223,000,000
1,390,000,000
1,361,000,000
1,398,000,000
1,141,000,000
1,064,000,000
969,000,000
1,683,000,000
1,035,000,000
1,000,000,000
957,000,000
1,570,000,000
1,086,000,000
1,196,000,000
1,001,000,000
1,256,000,000
1,032,000,000
1,126,000,000
957,000,000
1,075,000,000
1,129,000,000
864,000,000
1,193,000,000
1,062,000,000
1,064,000,000
998,000,000
882,000,000
1,062,780,000
987,000,000
925,000,000
813,000,000
857,523,000
681,868,000
684,663,000
634,448,000
675,818,000
597,269,000
617,345,000
580,931,000
584,447,000
531,989,000
533,863,000
474,111,000
496,337,000
477,584,000
455,525,000
440,430,000
473,399,000
409,700,000
383,045,000
329,414,000
321,531,000
300,183,000
265,684,000
239,848,000
215,542,000
198,460,000
183,131,000
171,638,000
155,289,000
109,791,000
77,883,000
90,357,000
74,144,000
65,498,000
63,269,000
57,415,000
48,704,000
40,842,000
42,092,000
34,949,000
33,277,000
25,936,000
32,106,000
21,372,000
19,552,000
20,412,000
17,718,000
12,042,000
13,178,000
9,208,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.